Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company founded in 2000 and based in Paris, France, with additional offices in Allston, MA, USA, and Shanghai, China. The company specializes in advanced medical imaging technology, particularly through its flagship product, Cellvizio®, the first and only real-time in vivo cellular imaging system. This platform allows for high-magnification visualization of cellular structures inside the body, enhancing clinical diagnosis and management in various medical specialties, including oncology, gastroenterology, and neurosurgery. The Cellvizio® platform is a confocal laser endomicroscopy system that provides real-time microscopic imaging during medical procedures. It has received regulatory clearance in the United States and over 40 countries, supporting multiple clinical applications and improving patient outcomes. Mauna Kea Technologies collaborates with industry leaders like Johnson & Johnson and Telix Pharmaceuticals to expand the reach of Cellvizio® and develop innovative treatments. The technology is utilized by healthcare professionals in hospitals and ambulatory surgery centers, having been involved in over 100,000 patient procedures.

• Employees 68
• Founded 2000
• Annual Revenue $8022000
• Total Funding $52099125